The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce it has entered into a definitive agreement for the exclusive distribution of Yield Growth’s line of mushroom infused organic coffees being developed through subsidiary Flourish Mushroom Labs Inc.
Organic Mushroom Coffees to be sold in Greece, Cyprus, Romania, Bulgaria and Serbia
To view an enhanced version of this graphic, please visit:
The distribution agreement grants exclusive distribution rights in Greece, Cyprus, Romania, Bulgaria and Serbia for the organic mushroom coffee line being developed by Yield Growth subsidiary Flourish Mushroom Labs to 2699598 Ontario Corp. O/A Melorganics Hellas. The term of the agreement is three years and exclusivity is maintained provided that minimum orders of $100K per year are met. The initial line of mushroom coffee mixes will be organic and infused with various wild mushrooms such as Lion’s Mane, Turkey Tail, Reishi, Shitake, Chagas and Cordyceps. Distribution will begin in Europe after regulatory approvals have been obtained.
In the second quarter of 2019 Greece was the fastest-growing Eurozone economy, according to eulerhermes.com, driven by strong growth in public consumption.
“Mushrooms are a unique source of vitamin D and some B vitamins… Mushrooms have long been used in Chinese medicine and newer research shows they are the highest dietary source of the antioxidants ergothioneine and glutathione, which help protect the body against the type of damage that can eventually contribute to age-related diseases like cancer, heart disease, Parkinson’s and Alzheimer’s,” says Beth Warren, RDN, founder of Beth Warren Nutrition, as reported in Yahoo Lifestyle.
Flourish Mushroom Labs has also announced its intention to develop clinical trials to research innovative therapeutic uses of certain compounds found in magic mushrooms, such as psilocybin. COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for its psilocybin therapy for treatment-resistant depression.
According to Drugpolicy.org, “Today, there are dozens of studies taking place to evaluate the medical safety and efficacy of psychedelics, including psilocybin, and the potential benefits of psychedelics as a treatment for cluster headache, anxiety, addiction to alcohol and other drugs, depression, obsessive-compulsive disorder, as well as neuroimaging experiments furthering the understanding of its effects on the brain.”
About Flourish Mushroom Labs Inc.
Created by and incubated by the team at The Yield Growth Corp., Flourish Mushroom Labs aims to be a leader in the fast growing functional foods market-and improve life by offering high-quality mushroom-infused products that naturally support better health. Flourish Mushroom Labs is investigating patentability of innovative therapeutic uses of magic mushrooms and plans to research into therapeutic benefits of some of the compounds found in magic mushrooms through clinical trials.
About The Yield Growth Corp.
The Yield Growth Corp. is developing and selling hemp, marijuana and mushroom products in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. It owns the cannabis wellness brands Urban Juve, Wright & Well and Jack n Jane. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers and Aritzia. Its all natural hemp skincare brand, Urban Juve, has signed distribution agreements in Canada, Colombia, Brazil, Greece, Cypress, Bulgaria, Romania and Serbia. Yield Growth’s Wright & Well brands are launching a THC/CBD line of topical and edible products in Oregon this month and a CBD from hemp topicals line in California in 2020. Through its subsidiaries, Yield Growth has over 200 proprietary beauty, wellness, edibles and beverage formulas for commercialization. It has filed 12 patents to protect its extraction method and formulas. Yield Growth is in revenue through multiple streams including licensing, services and product sales.
Investor Relations Contacts:
Penny White, President & CEO
Kristina Pillon, Investor Relations
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve, Wright & Well, Flourish Mushroom Labs, Jack n Jane and UJ Beverages products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49922